Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Operating Income (2022 - 2025)

Historic Operating Income for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to -$74784.0.

  • Cannabis Bioscience International Holdings' Operating Income rose 2338.02% to -$74784.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$398545.0, marking a year-over-year decrease of 440.74%. This contributed to the annual value of -$421365.0 for FY2025, which is 1332.44% up from last year.
  • Per Cannabis Bioscience International Holdings' latest filing, its Operating Income stood at -$74784.0 for Q3 2025, which was up 2338.02% from -$134900.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' Operating Income's 5-year high stood at -$29634.0 during Q2 2024, with a 5-year trough of -$284866.0 in Q1 2023.
  • Its 4-year average for Operating Income is -$141701.8, with a median of -$132067.0 in 2025.
  • In the last 5 years, Cannabis Bioscience International Holdings' Operating Income skyrocketed by 8922.0% in 2024 and then plummeted by 35522.04% in 2025.
  • Cannabis Bioscience International Holdings' Operating Income (Quarter) stood at -$183608.0 in 2022, then surged by 48.53% to -$94512.0 in 2023, then skyrocketed by 36.91% to -$59627.0 in 2024, then dropped by 25.42% to -$74784.0 in 2025.
  • Its Operating Income was -$74784.0 in Q3 2025, compared to -$134900.0 in Q2 2025 and -$129234.0 in Q1 2025.